Full-text search

Results for “Cowen”

Search across the indexed text of every released document.

63 documents found

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024846.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 - Figure 33 Lord Jones Price Point Reflects Premium Positioning Figure 34 CV’s Plus CBD Oil Competitively Positioned Within Premium 23 HIGH CBD PAIN & WELLNESS FORMULA TINCTURE HIGH CBD PAIN & WELLNESS FORMULA TINCTURE PEPPERM...

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024890.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 We Would Expect Starbucks To Be First Under Our Active Coverage To Pilot CBD Oil, Though Not In Near Term Plan (Charles) Under our active coverage, we would categorize Starbucks as the most forward thinking with beverage innovation...

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024853.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 Figure 53 Mary’s Provides A Range Of Topicals, Including Muscle Freeze 2 Figure 54 Curaleaf Hemp Lotion Priced On The Premium Side as MEDICINALS~ MUSCLY { FREEZE ELITE CBD CHIGIEGE HEMP LOTION LEMONGRASS cute, EMONGRAS H...

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024919.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 GW Pharmaceuticals Ple Rating History as of 02/25/2019 powered by: BlueMatrix (1):$166.00 || (1):$165.00 || (1):$175.00 02/24/17 08/07/17 09/27/18 180 160 140 120 100 80 60 40 20 Apr 16 Jul 16 Oct 16 Jan 17 Apr 17 Jul 17 Oct 17...

supplements, regardless of whether the substances are hemp-derived. This is because
document IMAGES-008-HOUSE_OVERSIGHT_024892.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS 76 February 25, 2019 supplements, regardless of whether the substances are hemp-derived. This is because both CBD and THC are active ingredients in FDA-approved drugs and were the subject of substantial clinical investigations before they were mark...

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024887.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 Adidas and Nau. Nike offered a hemp-based SB Dunk Low sneaker in 2004, re-issuing the shoe in 2016 around Earth Day. Patagonia, a $1B global brand that encompasses a focus on the environment and social responsibility in its mission...

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024893.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 Maine 2 Despite being one of 10 states to legalize marijuana for recreational use, health officials in Maine recently ordered businesses in the state to remove CBD-infused edibles from store shelves according to an article in the...

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024850.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 - Figure 44 CV Sciences Gummies Are Priced At A Premium Figure 45 Green Roads’ 300 MG Gummies Retail For $55 PLUS + i ba 67 wee 7 GREEN ROADS’ Rilspectum temp pares” HEMP GUMIMIES : RELAX BEARS © CBD DAILY DOSE GUMMIE = 30 GUMMI...

e Mary’s Whole Pet. Whole plant CBD remedies for pets, sold in retailers and
document IMAGES-008-HOUSE_OVERSIGHT_024878.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS 62 February 25, 2019 e Mary’s Whole Pet. Whole plant CBD remedies for pets, sold in retailers and online in the U.S. and international markets. Mary’s is a high-end brand, focused on clean delivery methods through its transdermal patches, topical...

Legend for Price Chart
document IMAGES-008-HOUSE_OVERSIGHT_024920.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS (1):$15.00 024/17 Jul 16 1:(1):$13.00 01/10/17 100 80 60 40 20 0 Apr 16 Legend for Price Chart: (1):$10.00 06/14/17 Oct 16 Canopy Growth Corporation Rating History as of 02/25/2019 Jan 17 February 25, 2019 powered by: BlueMatrix (1):$10.50...

Figure 128 Pooled LGS % Seizure Reduction: 10mg/kg Epidiolex vs
document IMAGES-008-HOUSE_OVERSIGHT_024908.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS 92 February 25, 2019 Figure 128 Pooled LGS % Seizure Reduction: 10mg/kg Epidiolex vs. Figure 129 Pooled LGS % Seizure Reduction: 20mg/kg Epidiolex vs. Placebo Placebo 100, our 100, oe 100 oars =79] (30% on VPA 100 pa =83] (38% on CLB Placebo [n=3...

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024897.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 beverages) will be imperative. This regulatory framework does not affect skincare, cosmetics or topicals with CBD or hemp ingredients. 2 Europe UK The UK legalized prescription based medical cannabis in November 2018. Medical can...

European Landscape
document IMAGES-008-HOUSE_OVERSIGHT_024896.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS 80 February 25, 2019 European Landscape European Parliament Resolution In February 2019, the European Parliament passed a significant resolution to create harmonized policies and standardized practices for medical cannabis products in the EV. The...

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024909.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 GW’s platform allows it to produce chemotypes with precise concentrations of various cannabinoids, and the company is testing numerous other cannabinoids. GW’s CBDV drug is in a 10 patient investigator sponsored trial in autism spec...